MTCO3P1: A Potential Drug Target for Brain Function (G404026)

Target Name: MTCO3P1

NCBI ID: G404026

MTCO3P1

Other Name(s): U92032.1 | MT-CO3 pseudogene 1

MTCO3P1: A Potential Drug Target for Brain Function

MTCO3P1 (U92032.1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of metal transmembrane proteins, which are a type of protein that is able to span the cell membrane and interact with various ions and molecules.

One of the unique features of MTCO3P1 is its ability to interact with the ionophore U101-8528, which is a protein that is involved in the regulation of ion channels in the brain. This interaction between MTCO3P1 and U101-8528 is important for the function of the ion channels, as U101-8528 plays a role in the regulation of the flow of calcium ions into the brain.

MTCO3P1 has also been shown to interact with the protein TREBP, which is involved in the production of brain-derived neurotrophic factor (BDNF), a protein that is involved in the regulation of brain function. This interaction between MTCO3P1 and TREBP suggests that MTCO3P1 may be a potential drug target or biomarker for the treatment of conditions that are related to the regulation of brain function, such as Alzheimer's disease or Parkinson's disease.

In addition to its interaction with U101-8528 and TREBP, MTCO3P1 has also been shown to interact with several other proteins, including the protein FBN1, which is involved in the regulation of blood clotting, and the protein PDGF-BB, which is involved in the regulation of cell growth and differentiation.

MTCO3P1 is also of interest because it is a protein that is expressed in the brain, and it is not typically found in other tissues. This suggests that it may be a unique drug target or biomarker for the treatment of conditions that are related to the regulation of brain function.

In conclusion, MTCO3P1 is a protein that is expressed in various tissues of the body, including the brain. It is a member of the superfamily of metal transmembrane proteins and has been shown to interact with U101-8528 and TREBP. These interactions suggest that MTCO3P1 may be a potential drug target or biomarker for the treatment of conditions that are related to the regulation of brain function. Further research is needed to determine the full function and potential applications of MTCO3P1.

Protein Name: MT-CO3 Pseudogene 1

The "MTCO3P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTCO3P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets